Pharmaceutical Technology on MSN1d
Boehringer Ingelheim and Salipro enter drug discovery partnershipThe partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
The One Medicine Platform replaces 20+ legacy platforms—unifying medicinal development processes & data sources into a ...
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...
Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung juries. November 22 ...
Boehringer Ingelheim Malaysia has again been recognised as a 'Top Employer' in the Malaysian market for the seventh ...
The US Food and Drug Administration (FDA) has granted priority review to Boehringer Ingelheim’s new drug application (NDA) for zongertinib to treat unresectable or metastatic non-small cell lung ...
Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback